Why Is Fate Therapeutics (FATE) Down 14.1% Since Last Earnings Report?
nasdaq.com
news
2022-06-03 11:31:00

A month has gone by since the last earnings report for Fate Therapeutics (FATE). Shares have lost about 14.1% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Fate Therapeutics due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.

FATE's Loss Narrower Than Expected in Q1, Pipeline in Focus

FATE reported a loss of 68 cents per share in the first quarter of 2022, narrower than the Zacks Consensus Estimate of a loss of 78 cents but wider than the year-ago loss of 49 cents.
